Page last updated: 2024-08-17

reserpine and cabergoline

reserpine has been researched along with cabergoline in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Arai, N; Isaji, M; Itoh, F; Kojima, M; Komatsu, Y; Miyagi, M; Taya, F	1
Bloch, DA; Elkashef, A; Leiderman, DB; LoCastro, J; Montgomery, A; Shoptaw, S; Vocci, F	1

Reviews

1 review(s) available for reserpine and cabergoline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for reserpine and cabergoline

Article	Year
Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. Addiction (Abingdon, England), 2005, Volume: 100 Suppl 1 Topics: Adolescent; Adult; Antipsychotic Agents; Cabergoline; Cocaine-Related Disorders; Dopamine Agonists; Double-Blind Method; Ergolines; Female; Humans; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Prospective Studies; Reproducibility of Results; Reserpine; Tiagabine	2005

Article

Year

Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence.

Addiction (Abingdon, England), 2005, Volume: 100 Suppl 1

Topics: Adolescent; Adult; Antipsychotic Agents; Cabergoline; Cocaine-Related Disorders; Dopamine Agonists; Double-Blind Method; Ergolines; Female; Humans; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Prospective Studies; Reproducibility of Results; Reserpine; Tiagabine

2005

Other Studies

2 other study(ies) available for reserpine and cabergoline

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine-treated rodents. Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:11 Topics: Animals; Cabergoline; Dopamine Agonists; Ergolines; Levodopa; Male; Mice; Motor Activity; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine	1996

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine-treated rodents.

Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:11

Topics: Animals; Cabergoline; Dopamine Agonists; Ergolines; Levodopa; Male; Mice; Motor Activity; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine

1996